Among them, cannabidiol (CBD), a non-psychoactive component of Cannabis sativa, has emerged as a promising molecule with potential preventive and therapeutic effects in various cancers, and an excellent recent review has summarized the role of CBD, primarily through CB1 and CB2 receptors, as potential therapeutic agent in liver cancer is available [7]. This evidence concerns the gene CNR1 and liver cancer.